Incentives for me-too drugmakers can help fix high drug prices

08/14/2014 | Forbes

Drug prices are incomprehensible and the cost of oncology treatments keeps rising, writes Dr. Peter Bach of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center. Incentives should be in place for drugmakers to bring me-too treatments to market in order to undercut the prices of competing therapies, and insurers' policies should help those companies gain market share, Bach writes.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC